Skip to main content
KNSA logo

KNSA · Kiniksa Pharmaceuticals International, plc

Track KNSA — free
$76.75 -1.08 (-1.39%) At close · Aug 14
Market Cap
$11.98B
Shares
156.05M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-07-29 Cole G Bradley 3,673
2026-07-29 Tessari Eben 67,062
2026-05-01 Paolini John F. 58,424
2026-04-28 Patel Sanj K 344,591
2026-04-09 Megna Michael R 6,625
2026-04-09 Moat Ross 1,703
2026-04-06 Quart Barry D 20,000
2026-04-06 Patel Sanj K 219,591
2026-04-06 Moat Ross 2,367
2026-03-09 Ragosa Mark 36,722
2026-03-02 Paolini John F. 40,000
2025-12-15 Quart Barry D 58,889
2025-12-08 Ragosa Mark 72,686
2025-11-26 Tessari Eben 48,384
2025-11-17 Tessari Eben 12,470
2025-10-31 Paolini John F. 82,542
2025-10-28 Ragosa Mark 20,000
2025-10-28 Ragosa Mark 20,000
2025-10-20 Megna Michael R 50,490
2025-10-20 Patel Sanj K 257,969
2025-10-14 Tessari Eben 12,368
2025-09-29 Tessari Eben 42,000
2025-09-15 Tessari Eben 16,400
2025-09-05 Tessari Eben 13,389
2025-09-04 Moat Ross 3,523
2025-09-04 Tessari Eben 85,271
2025-09-03 Tessari Eben 15,091
2025-09-03 Megna Michael R 11,000
2025-08-18 Tessari Eben 16,200
2025-08-14 Malley Thomas 78,233
2025-08-13 Malley Thomas 50,129
2025-08-12 Malley Thomas 49,407
2025-08-06 Paolini John F. 29,325
2025-08-05 Tessari Eben 138,614
2025-08-04 Megna Michael R 17,000
2025-08-04 Ragosa Mark 18,889
2025-07-30 KIMBERLY J. POPOVITS 64,508
2025-07-14 Tessari Eben 18,900
2025-06-16 Tessari Eben 17,300
2025-06-11 Tessari Eben 45,042
2025-06-10 Tessari Eben 15,506
2025-06-09 Tessari Eben 10,319
2025-06-09 Quart Barry D 27,448
2025-06-03 Moat Ross 27,594
2025-06-03 Ragosa Mark 18,299
2025-06-03 Megna Michael R 15,211
2025-05-19 Tessari Eben 12,000
2025-05-07 Patel Sanj K 99,586
2025-05-07 Megna Michael R 17,647
2025-05-07 Paolini John F. 29,525
Showing 1–50 of 87 filings
Key facts CIK 1730430 CUSIP G52694109 13F (30d) 257 filings 254 filers Visit website Investor relations